Chemours Co (CC)

Cash ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cash and cash equivalents US$ in thousands 713,000 596,000 619,000 746,000 1,807,000 852,000 738,000 816,000 1,102,000 1,167,000 1,248,000 1,145,000 1,451,000 1,031,000 1,139,000 1,008,000 1,105,000 956,000 1,031,000 714,000
Short-term investments US$ in thousands 50,000 178,000 167 182
Total current liabilities US$ in thousands 1,803,000 1,777,000 1,557,000 2,231,000 2,486,000 2,195,000 2,190,000 1,745,000 1,891,000 1,951,000 1,886,000 1,775,000 1,858,000 1,779,000 1,674,000 1,501,000 1,442,000 1,308,000 1,156,000 1,343,000
Cash ratio 0.40 0.36 0.40 0.33 0.73 0.39 0.34 0.47 0.58 0.60 0.66 0.65 0.78 0.58 0.79 0.67 0.77 0.73 0.89 0.53

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($713,000K + $—K) ÷ $1,803,000K
= 0.40

The cash ratio of Chemours Co has fluctuated over the period from March 31, 2020, to December 31, 2024. The cash ratio provides insight into the company's ability to cover its short-term liabilities using its cash and cash equivalents. A higher cash ratio indicates a stronger liquidity position.

The company's cash ratio ranged from a low of 0.33 on March 31, 2024, to a high of 0.89 on June 30, 2020. Despite fluctuations, the cash ratio generally remained above 0.5, indicating that Chemours Co maintained a sufficient level of cash reserves relative to its current liabilities.

Notably, there were occasional peaks and troughs in the cash ratio, suggesting potential variability in the company's ability to meet short-term obligations solely with cash on hand. It is important for investors and analysts to closely monitor changes in the cash ratio to assess the company's liquidity position and financial health.